Search
for
Sort by
Research 901–930 of 1000+
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Human umbilical cord blood mesenchymal stem cells engineered to overexpress growth factors accelerate outcomes in hair growth
- Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne
- Low Starch/Low Dairy Diet Results in Successful Treatment of Obesity and Co- Morbidities Linked to Polycystic Ovary Syndrome (PCOS)
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- PCOS: update and diagnostic approach
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Therapeutic options in the polycystic ovary syndrome
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
- Current aspects of polycystic ovary syndrome: A literature review
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Application of Cell-Derived Extracellular Vesicles and Engineered Nanovesicles for Hair Growth: From Mechanisms to Therapeutics
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- Ethyl acetate fraction of Eclipta alba: a potential phytopharmaceutical targeting adipocyte differentiation
- Ethinylestradiol/Chlormadinone Acetate
- Hirsutism and virilization
- Testosterone in Women: Measurement and Therapeutic Use
- Male fertility and skin diseases
- Interventional studies for polycystic ovarian syndrome in children and adolescents
- Measurement of steroid hormones by liquid chromatography-tandem mass spectrometry with small amounts of hair
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Regeneration of hair and other skin appendages: A microenvironment‐centric view
- Progestogens in menopausal hormone therapy
- A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- The local hypothalamic–pituitary–adrenal axis in cultured human dermal papilla cells
- CYP21A2 Mutations in Women with Polycystic Ovary Syndrome (PCOS)